A rare case of prostatic malakoplakia with multidrug-resistant Escherichia coli: a case report.
Escherichia coli
Malakoplakia
mNGS
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
31 Oct 2024
31 Oct 2024
Historique:
received:
12
07
2024
accepted:
29
10
2024
medline:
1
11
2024
pubmed:
1
11
2024
entrez:
1
11
2024
Statut:
epublish
Résumé
Prostatic malakoplakia is an uncommon chronic inflammatory disorder, tumor-like but non-cancerous, the diagnosis of which pivots crucially on the identification of characteristic Michaelis-Gutmann bodies within the pathological tissue. We hereby present an inaugural case report of prostatic malakoplakia concurrent with sepsis caused by multidrug-resistant Escherichia coli, verified through blood culture and metagenomic next-generation sequencing (mNGS). The pathogenesis might be associated with infections by Escherichia coli, immune system irregularities, or lysosomal dysfunction. Although the patient had no chronic underlying diseases, he presented early with sepsis and multi-organ dysfunction. This case emphasizes the imperative to further investigate the association between malakoplakia and Escherichia coli, the necessity for prompt diagnosis, and the supportive role of mNGS, and the treatment strategy focuses on rapid control of infection and systemic inflammatory response.
Identifiants
pubmed: 39482600
doi: 10.1186/s12879-024-10144-2
pii: 10.1186/s12879-024-10144-2
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1226Informations de copyright
© 2024. The Author(s).
Références
Acosta AM, Sangoi AR, Maclean F, Trpkov K, Osunkoya AO, Collins K, Miyamoto H, Hirsch MS, Chan E, Tretiakova M, et al. Prostatic malakoplakia: clinicopathological assessment of a multi-institutional series of 49 patients. Histopathology. 2022;81(4):520–8.
doi: 10.1111/his.14729
pubmed: 35876721
Bidot S, Lay AH, Harri PA, Harik LR. Exuberant Malakoplakia of the Prostate Presenting as Prostatic Abscesses in an Immunocompromised Patient. J Endourol Case Rep. 2020;6(3):231–4.
doi: 10.1089/cren.2020.0050
pubmed: 33102734
pmcid: 7580642
Chaudhry N, Vazzano J, Parwani A. Case study: Malakoplakia of the bladder. Pathol Res Pract. 2022;237:153852.
doi: 10.1016/j.prp.2022.153852
pubmed: 35878530
Palaoro L, Guerra F, Rocher A, Angeleri A, Juarez M, Coliva G. von Hansemann cells from fresh urine sediment samples in the diagnosis of malakoplakia. J Cytol. 2019;36(3):165–8.
doi: 10.4103/JOC.JOC_45_17
pubmed: 31359917
pmcid: 6592115
Rances OT, So JS. A Rare Case of Prostatic Malakoplakia Associated with Prostate Adenocarcinoma: A Case Report and Review of Literature. Acta Med Indones. 2023;55(3):339–42.
pubmed: 37915161
Kinsella PM, Smibert OC, Whitlam JB, Steven M, Masia R, Gandhi RG, Kotton CN, Holmes NE. Successful use of azithromycin for Escherichia coli–associated renal allograft malakoplakia: a report of two cases. Eur J Clin Microbiol Infect Dis. 2021;40(12):2627–31.
doi: 10.1007/s10096-021-04270-x
pubmed: 33990891
Jung YS, Chung DY, Kim EJ, Cho NH. Ultrastructural evidence of the evolutional process in malakoplakia. Histol Histopathol. 2020;35(2):177–84.
pubmed: 31298302
Ren Y, Chen W, Zhang M, Zhang X, Zhou J, Li Y, Cai D. Case report: Prostatic malakoplakia: a rare disease that has a profile mimicking prostate cancer. Front Oncol. 2024;14:1348797.
doi: 10.3389/fonc.2024.1348797
pubmed: 38665958
pmcid: 11043519
Alsaeed M, Mursi M, Eltayeb N, Kuriry H, Albaghli S, Alrusayni Y. Bifocal malakoplakia in a patient living with HIV: case report. AIDS Res Ther. 2024;21(1):3.
doi: 10.1186/s12981-024-00592-w
pubmed: 38185638
pmcid: 10771658
Lee EJ, Park H, Park SJ, Cho HR, Park KS, Park J, Yoo KD, Lee JS, Kim M, Cha HJ. Outgrowing skin involvement in malakoplakia after kidney transplantation: A case report. Transpl Proc. 2022;54(6):1627–31.
doi: 10.1016/j.transproceed.2022.03.055
Polisini G, Delle Fave RF, Capretti C, Marronaro A, Costa AM, Quaresima L, Mazzaferro D, Galosi AB. Malakoplakia of the urinary bladder: A review of the literature. Arch Ital Urol Androl. 2022;94(3):350–4.
doi: 10.4081/aiua.2022.3.350
pubmed: 36165484
Zhang Y, Byrnes K, Lam-Himlin D, Pittman M, Pezhouh M, Gonzalez RS, Alruwaii Z, Larman T, Miller JA, Matoso A, et al. Gastrointestinal Malakoplakia: Clinicopathologic Analysis of 26 Cases. Am J Surg Pathol. 2020;44(9):1251–8.
doi: 10.1097/PAS.0000000000001491
pubmed: 32301754
Lambden S, Laterre PF, Levy MM, Francois B. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019;23(1):374.
doi: 10.1186/s13054-019-2663-7
pubmed: 31775846
pmcid: 6880479
Das CJ, Razik A, Sharma S, Verma S. Prostate biopsy: when and how to perform. Clin Radiol. 2019;74(11):853–64.
doi: 10.1016/j.crad.2019.03.016
pubmed: 31079953
Guo Y, Li H, Chen H, Li Z, Ding W, Wang J, Yin Y, Jin L, Sun S, Jing C, et al. Metagenomic next-generation sequencing to identify pathogens and cancer in lung biopsy tissue. EBioMedicine. 2021;73: 103639.
doi: 10.1016/j.ebiom.2021.103639
pubmed: 34700283
pmcid: 8554462
Gu W, Miller S, Chiu CY. Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection. Annu Rev Pathol. 2019;14:319–38.
doi: 10.1146/annurev-pathmechdis-012418-012751
pubmed: 30355154
Diao Z, Han D, Zhang R, Li J. Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections. J Adv Res. 2022;38:201–12.
doi: 10.1016/j.jare.2021.09.012
pubmed: 35572406
Denamur E, Clermont O, Bonacorsi S, Gordon D. The population genetics of pathogenic Escherichia coli. Nat Rev Microbiol. 2021;19(1):37–54.
doi: 10.1038/s41579-020-0416-x
pubmed: 32826992
Wang D, Hu MT, Liu WJ, Zhao Y, Xu YC. Bacteremia caused by Nocardia farcinica: a case report and literature review. BMC Infect Dis. 2024;24(1):381.
doi: 10.1186/s12879-024-09230-2
pubmed: 38589778
pmcid: 11003049